Searched over 200M research papers
10 papers analyzed
These studies suggest that normal triglyceride levels generally range from 70-149 mg/dL, with variations influenced by age, weight, gender, and menopausal status.
20 papers analyzed
The National Cholesterol Education Program defines a fasting triglyceride level below 150 mg/dL as normal. This threshold is widely accepted in clinical practice, with levels under 150 mg/dL considered the upper limit of the normal range. However, some studies suggest that a more optimal cutpoint for assessing coronary heart disease (CHD) risk might be lower, specifically below 100 mg/dL.
Research indicates that triglyceride levels can vary significantly based on age and gender. For instance, serum triglyceride levels tend to rise with age, peaking in the forties, and then decline. Men generally have higher triglyceride levels compared to women, particularly in the age group of 40-49 years. Postmenopausal women also exhibit higher triglyceride levels compared to their premenopausal counterparts.
Non-fasting triglyceride levels also provide valuable insights. In a study of healthy Dutch males and females, non-fasting triglyceride concentrations were higher in males compared to females, with the highest levels observed in the evening. These findings help delineate normal ranges for non-fasting triglycerides, which can be useful for identifying individuals at risk for atherosclerosis.
Elevated triglyceride levels, even within the normal range of 100-149 mg/dL, have been associated with systemic inflammation, as indicated by higher C-reactive protein (CRP) levels. This suggests that triglyceride levels above 100 mg/dL may still pose a risk for CHD, highlighting the potential need for a lower threshold in risk assessments.
High triglyceride levels are linked to an increased risk of cardiovascular events. For example, individuals with high triglyceride and low high-density lipoprotein (HDL) levels are at a significantly higher risk for coronary artery disease. Moreover, a study on pemafibrate, a drug that lowers triglyceride levels, showed that while it effectively reduced triglyceride and other lipid levels, it did not significantly lower the incidence of cardiovascular events.
In summary, while the widely accepted normal range for fasting triglycerides is below 150 mg/dL, emerging evidence suggests that a lower threshold of below 100 mg/dL might be more optimal for assessing CHD risk. Triglyceride levels vary by age, gender, and fasting status, and elevated levels are associated with systemic inflammation and increased cardiovascular risk. These insights underscore the importance of considering individual patient characteristics and potential risk factors when evaluating triglyceride levels.
Most relevant research papers on this topic